我国动物源细菌耐药性监测系统简介

本文介绍了我国动物源细菌耐药性监测网络的组成和主要内容,详细阐述了其过程控制,包括采样、细菌分离鉴定和耐药性检测、耐药性检测结果汇总分析等,并介绍了我国取得的成就,如建立了动物源细菌耐药性监测技术平台和耐药性细菌资源库、创建了具有自主知识产权的动物源细菌耐药性数据库、摸清了我国动物源细菌的耐药性状况等。针对我国动物源细菌的耐药现状,提出了应对措施,包括规范我国兽用抗菌药物饲料添加剂的使用、加强动物处方药的管理并建立治疗用抗菌药物的分级管理制度、持续开展畜禽细菌耐药性动态监测等。     

我国动物源细菌耐药状况、存在问题和对策

动物源细菌耐药性问题不仅关系到动物的用药安全,也与公共卫生安全密切相关,日益引起各国的关注。中国兽医药品监察所从事动物源细菌耐药性检测工作10余年,对我国动物源细菌的耐药性状况进行了系统的调查。本文从动物源细菌耐药性监测工作的重要性、我国动物源细菌的耐药性状况、存在的问题以及应对策略四个方面进行了综述,以期对我国的动物源细菌耐药性监测工作起一定的参考作用。     

我国动物源细菌耐药性数据库的建立与应用

为加强全国动物源细菌耐药性监测数据统一管理,实时掌握我国动物源细菌耐药性的流行动态,中国兽医药品监察所联合多家国内细菌耐药性监测单位,开发了我国的动物源细菌耐药性监测数据库。该数据库为B/S架构,全国不同地区动物源细菌耐药性监测实验室均可通过网页浏览器连接服务器,实现了监测数据即时储存、统计分析和上报,为我国兽医临床细菌耐药性监测提供了重要的技术支持。     

我国动物源细菌耐药性监测及预警的研究进展

利用调查和数据统计报道我国近年来的兽用抗生素使用、养殖业用药背景、抗菌药物耐药、动物源细菌耐药性监测、动物源细菌耐药监测数据库研究及国家制定的相关政策等现状,并针对我国动物源细菌的耐药和监测现状,提出了我国政府与各地区相关部门应科学评估分析动物源细菌耐药性监测数据及变化趋势;借鉴发达国家的经验和方法,完善我国动物源细菌耐药性监测网络和监测体系;加强教育和宣传等应对措施,为解决全球动物源细菌耐药性问题作出贡献。     

要闻

农业部印发《2013年动物源细菌耐药性监测计划》根据《兽药管理条例》规定,为做好2013年度动物源细菌耐药性监测工作,进一步提高我国细菌耐药性监测能力,农业部特制定《2013年动物源细菌耐药性监测计划》。各监测任务承担单位的采样、细菌分离和鉴定、耐药性检测和结果上报等活动要按照《动物源细菌耐药性检测采样、检测技术要点》;样品应从畜禽养殖场、屠宰     

浅析动物源细菌抗生素耐药性的现状与对策

抗生素的滥用使细菌耐性问题日趋恶化,从细菌耐药性的定义、耐药机理及危害出发,简要阐述和分析了动物源细菌抗菌药物耐药性的现状及对策,并简述我国动物源细菌耐药性研究进展。     

动物源细菌耐药性监测与流行病学研究

全面分析了开展动物源细菌耐药性监测与流行病学研究的必要性和紧迫性,介绍了动物源细菌耐药性监测与流行病学研究的国外概况和国内现状,指出当前我国在该领域内存在的问题,提出6点建议以期做好动物源细菌耐药性的防控工作。     

2020年动物源细菌耐药性监测工作总结会在京召开

近日,中国兽医药品监察所在北京召开2020年动物源细菌耐药性监测工作总结会。中国兽医药品监察所副所长高光、农业农村部畜牧兽医局药政药械处副处长冯华兵及相关专家出席会议。会议总结了2020年全国动物源细菌耐药性监测工作情况,全面分析了我国动物源细菌耐药性变化趋势,讨论了耐药性监测工作中存在的问题及改进措施,研究制定了2021年动物源细菌耐药性监测计划。     

国家动物源细菌耐药性监测工作的探讨和建议

介绍了国外动物源细菌耐药性监测工作的情况及目标,对我国的动物源细菌耐药性监测工作需考虑的许多因素进行了介绍和讨论,包括动物品种、食品、采样方法、样本的收集、细菌品种、抗菌药物、标准药敏试验法、质控、结果记录和数据库设计、报告和结果分析等,并对今后的动物源细菌耐药性监测工作提出了建议。     

日本兽用抗菌药耐药性监控系统及风险管理

介绍日本兽用抗菌药耐药性监控系统并分析日本食品动物源细菌耐药现状和抗菌药使用情况,以期为我国动物源细菌耐药性监控管理提供参考和借鉴。     

beta-Lactam resistance and beta-lactamases in bacteria of animal origin

beta-Lactams are among the most clinically important antimicrobials in both human and veterinary medicine. Bacterial resistance to beta-lactams has been increasingly observed in bacteria, including those of animal origin. The mechanisms of beta-lactam resistance include inaccessibility of the drugs to their target, target alterations and/or inactivation of the drugs by beta-lactamases. The latter contributes predominantly to beta-lactam resistance in Gram-negative bacteria. A variety of beta-lactamases have been identified in bacteria derived from food-producing and companion animals and may further serve as a reservoir for beta-lactamase-producing bacteria in humans. While this review mainly describes beta-lactamases from animal-derived Escherichia coli and Salmonella spp., beta-lactamases from animal-derived Campylobacter spp., Enterococcus spp., Staphylococcus spp. and other pathogens are also discussed. Of particular concern are the increasingly-isolated plasmid-encoded AmpC-type CMY and extended-spectrum CTX-M beta-lactamases, which mediate acquired resistance to extended-spectrum beta-lactams. The genes encoding these enzymes often coexist with other antimicrobial resistance determinants and can also be associated with transposons/integrons, increasing the potential enrichment of multidrug resistant bacteria by multiple antimicrobial agents as well as dissemination of the resistance determinants among bacterial species. Characterization of beta-lactam-resistant animal-derived bacteria warrants further investigation of the type and distribution of beta-lactamases in bacteria of animal origin and their potential impact on human medicine.     

Research Progress on Salmonellosis Prevention and Control in Livestock and Poultry

Salmonella is a member of the Salmonella family of Enterobacteriaceae and has about 2 600 different serotypes. As a widely distributed conditional pathogen,it has a serious impact on animal health, public safety and food safety.Pathogenic Salmonella can cause paratyphoid fever, pullorosis, avian typhoid and avian paratyphoid, non-pathogenic Salmonella may cause the contamination of animal-derived food. With the rapid development of aquaculture in recent years, the adverse effects of Salmonella to livestock and poultry breeding industry is more and more terrible.Antibiotic resistance of Salmonella resulting from abuse of antimicrobial agents is becoming more serious,thereby increasing the difficulty of Salmonella control. In this paper, Salmonella clinical diagnosis, laboratory diagnosis, the problems of prevention and treatment were reviewed in order to provide a reference for the improvement of salmonellosis prevention and control of livestock and poultry.     

畜禽沙门氏菌病防制研究进展

沙门氏菌为肠杆菌科沙门氏菌属成员,具有约2 600种血清型,其在自然界中十分普遍,是一种条件致病菌,对畜禽健康、人类公共安全、食品安全都有严重的影响。近年来,随着养殖业的迅速发展,沙门氏菌对畜禽养殖业的影响越来越严重。实际生产中的抗生素滥用导致沙门氏菌的耐药状况愈发严重,致病性沙门氏菌可引起猪副伤寒、鸡白痢、禽伤寒、禽副伤寒等畜禽疾病,非致病性沙门氏菌可能造成动物源性食品的污染,加大了防制的难度。作者主要从沙门氏菌临床诊断、实验室诊断及预防和治疗中存在的问题进行了综述,以期为畜禽沙门氏菌病防制措施的改进提供参考依据。     

细菌的获得性耐药机制研究进展

抗菌药物的广泛使用,导致细菌耐药性日益严重,耐药菌所致的感染给人类健康及畜禽生产带来巨大威胁。细菌耐药可由多种机制所介导,研究细菌的耐药机制对防止或延缓耐药性的产生具有重要意义。近年来,影响药物与作用靶位结合及作用靶位结构变化等机制介导的耐药受到人们的关注。论文将对作用靶位变化导致细菌耐药问题的最新研究进展进行综述,以期为防止和延缓细菌耐药性的产生提供理论依据。     

动物源肠球菌对饲用抗菌促生长剂流行病学临界值的建立

【目的】建立动物源肠球菌对抗菌促生长剂的流行病学临界值,并基于此了解2019-2021年动物源肠球菌对饲用抗菌促生长剂的耐药情况。【方法】测定2019-2021年从北京、河北、四川、山西、陕西和内蒙古养殖场动物样本中分离得到的肠球菌对7种抗菌促生长剂（吉他霉素、黄霉素、恩拉霉素、那西肽、阿维拉霉素、维吉尼亚霉素和杆菌肽）的最小抑菌浓度（MIC）值。根据CLSI-VET中规定的方法,利用统计软件ECOFFinder对MIC分布数据进行非线性回归模拟,以95%置信区间下的流行病学临界值计算动物源肠球菌对7种抗菌促生长剂的耐药率。【结果】确定了动物源肠球菌对吉他霉素、黄霉素、恩拉霉素、那西肽、阿维拉霉素、维吉尼亚霉素和杆菌肽的流行病学临界值分别为8、8、8、0.25、8、8和32 μg/mL。由此计算的药物耐药率为64.38%、34.48%、80.06%、14.69%、19.06%、50.69%和24.96%,其中动物源肠球菌对恩拉霉素、吉他霉素和维吉尼亚霉素的耐药情况最为严重,而对那西肽最敏感。在2019-2021年的耐药率变化情况统计中,黄霉素和杆菌肽的耐药率下降趋势较为明显。【结论】本研究制定了动物源肠球菌对7种养殖业常用抗菌促生长剂的流行病学临界值,可作为动物源肠球菌对饲用抗菌促生长剂敏感和耐药的初步判定标准,为进一步制定耐药折点,监测动物源肠球菌对抗菌促生长剂的耐药情况变化提供数据基础和科学依据。     

Antimicrobial resistance in bacteria from food-producing animals. risk management tools and strategies

The application of antimicrobial agents has proved to be the main risk factor for development, selection and spread of antimicrobial resistance. This link applies to the use of antimicrobial agents in human and in veterinary medicine. Furthermore, antimicrobial-resistant bacteria and resistant genes can be transmitted from animals to humans either by direct contact or via the food chain. In this context, risk management has to be discussed regarding prevention and control of the already existing antimicrobial resistance. One of the primary risk management measures in order to control the development and spread of antimicrobial resistances is by regulating the use of antimicrobial agents and subjecting their use to guidelines. Thereby, the occurrence of antimicrobial resistant bacteria in the human and veterinary habitat can be controlled to a certain degree. There is little information about past attempts to prevent the development of resistances or to control them, and even less is known about the effectiveness or the cost intensiveness of such efforts. Most of the strategies focus on preventing and controlling antimicrobial resistance by means of the reduction or limitation of the use of antimicrobial agents in food-producing animals.     

黄酮类化合物抗菌作用及机制的研究进展

随着抗菌药物在临床预防与治疗中的广泛应用,细菌耐药性问题日趋严重,泛耐药菌株及多重耐药菌株显著增多。中草药因其特殊的抗菌机制而不易产生耐药性,使得抗耐药菌中草药的研发及其抗菌机制的研究越来越受到人们的关注。天然存在的黄酮类化合物具有一定的抗菌活性,其中大部分种类对金黄色葡萄球菌、链球菌和枯草杆菌等革兰氏阳性菌的抑制作用较明显,不良反应相对较轻,且不易出现耐药性。文章就黄酮类化合物的抗菌作用及机制作一综述。     

Antimicrobial use in food and companion animals

The vast literature on antimicrobial drug use in animals has expanded considerably recently as the antimicrobial resistance (AMR) crisis in human medicine leads to questions about all usage of antimicrobial drugs, including long-term usage in intensively managed food animals for growth promotion and disease prevention. Attention is also increasingly focusing on antimicrobial use and on bacterial resistance in companion animals, which are in intimate contact with the human population. They may share resistant bacteria with their owners, amplify resistant bacteria acquired from their owners, and act as a reservoir for human infection. Considerable effort is being made to describe the basis of AMR in bacterial pathogens of animals. Documentation of many aspects of use of antimicrobials in animals is, however, generally less developed and only a few countries can describe quantities of drugs used in animals to kg levels annually. In recent years, many national veterinary associations have produced 'prudent use guidelines' to try to improve antimicrobial drug use and decrease resistance, but the impact of guidelines is unknown. Within the evolving global movement for 'antimicrobial stewardship', there is considerable scope to improve many aspects of antimicrobial use in animals, including infection control and reduction of use, with a view to reducing resistance and its spread, and to preserving antimicrobial drugs for the future.